Skip to content
Optionomics Free · No account needed

Earnings analysis · 10-Q

VIVK earnings analysis

Filed August 19, 2026 · Our reading of the company's report

The latest report

The provided 10-Q extract does not include the income statement, balance sheet, cash flow statement, segment disclosures, or current-quarter revenue and EPS, so those metrics cannot be assessed from the filing text…

Read full summary

The provided 10-Q extract does not include the income statement, balance sheet, cash flow statement, segment disclosures, or current-quarter revenue and EPS, so those metrics cannot be assessed from the filing text supplied. The filing nevertheless highlights continued financial and reporting pressure: disclosure controls were ineffective as of June 30, 2026, material weaknesses remained unresolved, and significant debt obligations extend into October 2026 and beyond. Financing and debt conversions provided capital and reduced obligations, but the $12.0 million May financing and potential $100 million SEPA also create meaningful dilution risk. The filing states that there were no material changes to previously disclosed risk factors.

Read the original on SEC.gov

How we read each report

Our analysis across the last few reports.

Read as bullish Read as bearish Apr 2026 Aug 2026

Our model's reading of each filing, not the share price or the market's reaction. Annual and quarterly reports each occupy one position.

What stood out

  • $12 million financing completed

    The May 2026 financing provided up to $12.0 million of gross proceeds before fees and expenses, with $6.0 million received at the May 8 closing and an additional $6.0 million received at the July 16 closing. Management said proceeds would fund working capital, debt reduction, and general corporate purposes.

  • Debt reduced through note conversions

    Lenders converted $1,037,025 of outstanding notes into 104,501 common shares between June 4 and June 5, 2026, and converted an additional $1,628,113.78 into 214,522 shares between June 4 and June 17, 2026.

  • Nasdaq relisting achieved

    Nasdaq determined the company was compliant with the Minimum Bid Price Requirement, and trading resumed on April 27, 2026. The company remains subject to a Mandatory Panel Monitor for one year from the April 23, 2026 letter.

  • Additional equity capital available

    The company entered into a standby equity purchase agreement allowing potential purchases of up to $100 million of common stock over 36 months, subject to volume, registration, pricing, and ownership limitations.

  • Capital structure actions support listing

    The company effected a 1-for-20 reverse stock split on July 17, 2026, following an earlier 1-for-200 reverse split on March 24, 2026, addressing share-price and listing compliance requirements.

What to watch

  • Material weaknesses remain unresolved

    Management and the CFO concluded that disclosure controls were not effective as of June 30, 2026 because of material weaknesses tied to insufficient accounting personnel, segregation-of-duties deficiencies, and inadequate review controls. Management stated the weaknesses had not been fully remediated as of June 30, 2026.

  • Near-term debt and default risk

    The company has significant near-term debt obligations, including Cedarview notes with principal amounts of $3,000,000 and $3,670,160.77 that were extended only to October 31, 2026. The May 2026 Notes have aggregate principal of $15.0 million and contain default provisions that may accelerate amounts due.

  • Substantial equity dilution exposure

    The SEPA permits up to $100 million of equity purchases over 36 months, and the company must register 270,270,271 shares issuable under the agreement. Shares are generally sold at a discount to prevailing market prices, creating substantial potential dilution and financing-price pressure.

Management's outlook

The provided 10-Q text contains no quantitative revenue or EPS outlook and does not disclose a change to prior guidance. No numeric guidance was provided.

Earlier filings 2

10-Q · May 20, 2026

Vivakor reported Q4 2026 results with significant upswing in revenue to $21M, reflecting a 112.8% rise compared to the previous quarter and marked improvement in gross margin to 112.8%. However, the company posted a…

10-K · April 15, 2026

Vivakor presents an integrated midstream strategy spanning transportation, terminaling, marketing and a remediation business expected to begin operations in Q1 2026. The company expanded scale via material acquisitions…

This is our reading of a public filing, not the filing itself. Analysis can contain errors; check the source document for full context.